blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3748007

EP3748007 - GENE AUGMENTATION THERAPIES FOR INHERITED RETINAL DEGENERATION CAUSED BY MUTATIONS IN THE PRPF31 GENE [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  24.05.2024
Database last updated on 05.10.2024
FormerGrant of patent is intended
Status updated on  08.02.2024
FormerExamination is in progress
Status updated on  05.08.2022
FormerRequest for examination was made
Status updated on  11.06.2021
FormerThe application has been published
Status updated on  06.11.2020
Most recent event   Tooltip24.05.2024(Expected) grantpublished on 26.06.2024  [2024/26]
Applicant(s)For all designated states
Massachusetts Eye & Ear Infirmary
243 Charles Street
Boston, MA 02114 / US
[2020/50]
Inventor(s)01 / PIERCE, Eric A.
118 Goden Street
Belmont, MA 02478 / US
02 / FARKAS, Michael H.
11 Sean Riley No.1
Getzville, NY 14053-1492 / US
03 / SOUSA, Maria E.
20 Fairfield Street
Dedham, MA 02026 / US
 [2020/50]
Representative(s)Forresters IP LLP
Skygarden
Erika-Mann-Straße 11
80636 München / DE
[2020/50]
Application number, filing date20171646.107.03.2016
[2020/50]
Priority number, dateUS201562129638P06.03.2015         Original published format: US 201562129638 P
US201562147307P14.04.2015         Original published format: US 201562147307 P
[2020/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3748007
Date:09.12.2020
Language:EN
[2020/50]
Type: B1 Patent specification 
No.:EP3748007
Date:26.06.2024
Language:EN
[2024/26]
Search report(s)(Supplementary) European search report - dispatched on:EP01.10.2020
ClassificationIPC:C12N15/90, A61K9/00, A61K48/00, A61P27/02, // C12N15/113
[2020/50]
CPC:
A61K48/005 (EP,US); A61K9/0048 (EP,US); A61P27/02 (EP);
C12N15/63 (US); C12N15/90 (EP,US); C12N15/113 (EP,US);
C12N2310/20 (EP,US); C12N2750/14143 (EP,US); C12N2800/22 (EP,US);
C12N2830/008 (EP,US) (-)
C-Set:
C12N2310/14, C12N2310/531 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/28]  
Former [2020/50]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:GENAUGMENTATIONSTHERAPIEN FÜR HEREDITÄRE NETZHAUTDEGENERATION DURCH MUTATIONEN IM PRPF31-GEN[2020/50]
English:GENE AUGMENTATION THERAPIES FOR INHERITED RETINAL DEGENERATION CAUSED BY MUTATIONS IN THE PRPF31 GENE[2020/50]
French:THÉRAPIES D'AUGMENTATION GÉNÉTIQUE DE LA DÉGÉNÉRESCENCE RÉTINIENNE HÉRÉDITAIRE CAUSÉE PAR DES MUTATIONS AU NIVEAU DU GÈNE PRPF31[2020/50]
Examination procedure09.06.2021Amendment by applicant (claims and/or description)
09.06.2021Examination requested  [2021/28]
09.06.2021Date on which the examining division has become responsible
08.08.2022Despatch of a communication from the examining division (Time limit: M04)
15.12.2022Reply to a communication from the examining division
09.02.2024Communication of intention to grant the patent
17.05.2024Fee for grant paid
17.05.2024Fee for publishing/printing paid
17.05.2024Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP16762307.3  / EP3265568
Fees paidRenewal fee
27.07.2020Renewal fee patent year 03
27.07.2020Renewal fee patent year 04
27.05.2020Renewal fee patent year 05
29.03.2021Renewal fee patent year 06
28.03.2022Renewal fee patent year 07
27.03.2023Renewal fee patent year 08
27.03.2024Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO02082904  (UNIV PENNSYLVANIA [US], et al);
 [Y]WO2004084951  (UNIV NANTES [FR], et al);
 [A]WO2008137066  (UNIV OKLAHOMA [US], et al);
 [A]WO2009134681  (UNIV PENNSYLVANIA [US], et al);
 [A]WO2014011210  (UNIV PENNSYLVANIA [US], et al);
 [T]WO2015189429  (UNIV SANTIAGO COMPOSTELA [ES], et al);
by applicantJP1047381
 EP0043075
 WO8902468
 WO8905345
 WO8907136
 US4868116
 US4980286
 WO9106309
 WO9207573
 WO2015054653
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.